Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer's disease.
Alzheimers Dement
; 19(1): 261-273, 2023 01.
Article
en En
| MEDLINE
| ID: mdl-35357079
Palabras clave
Alzheimer disease; Lomecel-B; anti-inflammatory agents; biological therapy; bone marrow mesenchymal stem cell; clinical trial; cytokines; hippocampus; human bone marrow; inflammation; inflammation mediators; interleukins; medicinal signaling cell; mesenchymal stem cell; mesenchymal stromal cell; multipotent stem cells; neuroimaging; neuroinflammatory diseases; randomized controlled trial; regenerative medicine; vascular; vascular endothelial cell growth factor
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Enfermedad de Alzheimer
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
Límite:
Humans
Idioma:
En
Revista:
Alzheimers Dement
Año:
2023
Tipo del documento:
Article
País de afiliación:
Estados Unidos